<法規>
<法規性質>命令</法規性質>
<英文法規名稱>Regulations Governing the Management of Laboratory Diagnoses for Communicable Diseases and Laboratory Testing Institutions</英文法規名稱>
<中文法規名稱>傳染病檢驗及檢驗機構管理辦法</中文法規名稱>
<法規網址>http://law.moj.gov.tw/Eng/LawClass/LawContent.aspx?PCODE=L0050023</法規網址>
<最新英文異動日期>20131025</最新英文異動日期>
<廢止註記>
</廢止註記>
<附件>
  <下載網址>http://law.moj.gov.tw/Eng/Law/law_getfile.ashx?FileId=0000002232</下載網址>
</附件>
<沿革內容><![CDATA[1.Formulated and announced in 10 articles by the Department of Health, the Executive Yuan, on 29 July 2004, under Shu-Shou-Chi Order No. 0930000737
2.Amended the title (originally: Regulations Governing the Management of Designated Institutions for the Laboratory Testing of Communicable Diseases) and 11 articles and announced by the Department of Health, the Executive Yuan, on July 4, 2008, under Shu-Shou-Chi Order 0970000583
3.Amended 17 articles and the Appendix and announced by the Department of Health, the Executive Yuan, on November 28, 2012, under Shu-Shou-Chi Order No. 1010101381
4.Amended Article 3, Article 11, Article 16 and the Appendix and announced by the Ministry of Health and Welfare, on October 25, 2013, under Bu-Shou-Chi Order No. 1020103523]]></沿革內容>
<法規內容>
  <條文>
    <條號>Article 1</條號>
    <條文內容><![CDATA[This set of Regulations is formulated in accordance with regulations of Paragraph 2, Article 46 of the Communicable Disease Control Act (hereafter referred to as the Act).
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 2</條號>
    <條文內容><![CDATA[Terms used in this set of Regulation are defined as follows:
1. a laboratory testing institution can be a local health authority setup, a medical care organization, or an academic or research institute, which is engaging itself in collecting and testing/diagnosing communicable disease specimens, and has been either designated, commissioned, or authorized by the central competent authority for doing so;
2. a laboratory accreditation body is an organization capable of carrying out suitable inspection and assessment in order to certify the testing competency and quality of a laboratory against the international standards; and
3. a laboratory proficiency test for laboratory competency refers to a process of comparing its own testing results to those of other laboratories to evaluate the testing or correcting capability of the target laboratory.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 3</條號>
    <條文內容><![CDATA[Specimens of communicable diseases, items to be collected, timing of collection, method of shipping are regulated as described in the Attachment.
Appendix：Integrated Summaries of Regulations Governing Collection and Shipping of Disease Prevention Specimens
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 4</條號>
    <條文內容><![CDATA[Whenever spillage of a communicable disease specimen occurs and is spotted during shipment, the person doing or responsible for the shipping shall notify the shipper right away and the latter shall call the attention of the local municipality, city or county government of the incidence site at once and proceed to do whatever treatment is needed.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 5</條號>
    <條文內容><![CDATA[All personnel conducting either the initial collection or the later laboratory diagnoses of communicable disease specimens shall by all means take appropriate protective measures according to the risk level of the communicable disease involved.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 6</條號>
    <條文內容><![CDATA[The central competent authority may appoint institutions that meet the following qualifications as designated testing institutions for communicable diseases:
1. institutions that are equipped with bio-safety level III or level IV laboratory that meets the standards set by Regulations Governing the Management of Infectious Biological Materials;
2. institutions that are staffed with laboratory personnel qualified through bio-safety training; and
3. institutions that have sound laboratory bio-safety management measures and good documentation ability for dealing with specimens.
The designation mentioned in the preceding Paragraph may be based on, in addition to document review, onsite visit and inspection.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 7</條號>
    <條文內容><![CDATA[The central competent authority may select, through publicly announced selection procedures, institutions that meet the following qualifications as commissioned laboratory testing institutions for communicable diseases:
1. institutions that use the standard testing methods approved and regulated by the central competent authority;
2. institutions that have passed the laboratory proficiency tests;
3. institutions that have passed certain level of laboratory bio-safety certification cohering with the testing items commissioned and methods used; and
4. institutions that are equipped with appropriate laboratory bio-safety management manual or regulations brochure agreeing with the bio-safety level of the specimens they are operating on.
The commissioned laboratory testing institutions are authorized to conduct testing for Category II, Category III, or Category IV communicable diseases of the Act only.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 8</條號>
    <條文內容><![CDATA[Institutions that meet one of the following qualifications may apply to the central competent authority for authorized laboratory testing institutions for communicable diseases:
1. institutions that have passed the certification of the laboratory accreditation bodies; and
2. institutions that have passed the laboratory proficiency tests.
For the application mentioned in the preceding Paragraph, the following documents shall be submitted:
1. the application;
2. documents of qualification;
3. standard operating procedures of testing methods; and
4. possessing appropriate laboratory bio-safety management manual or regulations brochure agreeing with the bio-safety level of the specimens they are operating on.
The said authorized laboratory testing institutions are authorized to conduct testing for Category II, Category III, or Category IV communicable diseases of the Act only.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 9</條號>
    <條文內容><![CDATA[The validity of the designated, commissioned, or authorized laboratory testing institutions for communicable diseases shall be no longer than four years.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 10</條號>
    <條文內容><![CDATA[In the case of communicable diseases of Category I or Category V of the Act being involved, all laboratory testing institutions shall, within one month upon the completion of testing, send the leftover parts of the tested specimens to the central competent authority for safekeeping.
The designated or the commissioned laboratory testing institutions shall, within one month after the completion of their testing, send the pathogen isolates, and certified pathogen or its antibody-containing sera or plasma samples, which are derived from the specimens, to the central competent authority for.
For the needs of disease control, the central competent authority may notify the laboratory testing institutions to submit certain specimens or pathogen isolates in particular for safekeeping.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 11</條號>
    <條文內容><![CDATA[With the exception of specimens of Category 1 and Category 5 Communicable Diseases of the Act, laboratory testing institutions, upon completion of the laboratory testing reports, shall safekeep the specimens for at least three days before they can be destroyed. However, for pathogen isolates, if their biopsy, blood slide, serum, or plasma specimens are confirmed to contain pathogens or their antibodies, they shall be kept for at least thirty days before they can be destructed.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 12</條號>
    <條文內容><![CDATA[The laboratory testing institutions shall follow the testing time limits specified in the attached Table in Article 3 to complete the testing ordeals and write up the final reports before the deadline, plus to transmit the testing results to all levels of competent authorities above them.
When confronted with issues of specimen preservation, diagnostic quality and what to do when unexpected or extraordinary testing results are coming up as the laboratory testing institutions operate on communicable disease specimens, they shall follow the quality assurance procedures formulated and announced by the central competent authority.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 13</條號>
    <條文內容><![CDATA[The central competent authority may conduct investigation on the laboratory testing institutions for communicable diseases; the latter shall cooperate, and may not evade, obstruct, or refuse.
The investigation mentioned in the preceding Paragraph may be conducted in way of document reviews, proficiency tests, or onsite inspections.
If defects are detected at the investigation of the first Paragraph, the laboratory testing institutions shall make necessary corrections and complete them before the deadline specified by the central competent authority. If corrections are not made in due time, the central competent authority may decide to annul its former designation, authorization, or terminate its commission.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 14</條號>
    <條文內容><![CDATA[Should there be any alteration in the name, address, or person in charge of an authorized laboratory testing institutions, the central competent authority shall be notified by the institution within 30 days after the alteration. Should the institution temporarily suspend its business, go out of business permanently, or just lose part of its business capacity, the central competent authority shall be informed within 15 days after the change, so that it may annul its former approval of the institution’s part or the complete testing items.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 15</條號>
    <條文內容><![CDATA[The central competent authority may, at its own discretion, subsidize partially or totally the costs of the designated laboratory testing institutions for communicable diseases.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 16</條號>
    <條文內容><![CDATA[For matters specified in Article 6 through Article 8, and Article 13, the central competent authority may commission its subordinate the Centers for Disease Control or entrust relevant organizations (institutions) instead to act on its behalf.
]]></條文內容>
  </條文>
  <條文>
    <條號>Article 17</條號>
    <條文內容><![CDATA[This set of Regulations shall be implemented on the day of promulgation.
]]></條文內容>
  </條文>
</法規內容>
</法規>
